Neokay (Phytomenadione)

Neokay is a vitamin K used to manage disorders of coagulation and related bleeding risks.

• Vitamin K deficiency: restores normal clotting factor activity and stops bleeding.
• Newborn hemorrhage: prevents and treats bleeding in neonates due to low vitamin K stores.
• Warfarin reversal: counteracts anticoagulation caused by warfarin or other vitamin K antagonists.

• Phytomenadione provides vitamin K1 activity, acting as an essential cofactor for the gamma‑carboxylation of glutamate residues on clotting factors II, VII, IX and X. This enzymatic modification enables the synthesis of functional clotting factors, thereby correcting vitamin K deficiency‑related bleeding and reversing the effects of vitamin K antagonists.

Adverse reactions may occur with oral vitamin K therapy and should be monitored.

Common Side Effects

• Nausea: mild gastrointestinal upset.
• Diarrhea: loose stools occurring shortly after dosing.
• Abdominal pain: transient discomfort in the stomach area.
• Flushing: temporary redness of the skin.
• Headache: mild to moderate head pain.
• Dizziness: occasional light‑headed sensation.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Hemolysis: breakdown of red blood cells, presenting with fatigue and jaundice.
• Severe allergic reaction: rash, itching, swelling of face or throat.
• Elevated liver enzymes: indication of hepatic stress.
• Thrombosis: formation of abnormal blood clots.
• Hypotension: sudden drop in blood pressure.

When prescribing Neokay, consider the following safety measures.

• Assess vitamin K status: evaluate baseline coagulation parameters before initiation.
• Monitor anticoagulation: check INR or PT values regularly in patients on warfarin.
• Use with caution in liver disease: impaired synthesis of clotting factors may affect response.
• Avoid in known hypersensitivity: discontinue if allergic reactions develop.
• Pregnancy considerations: only use if the potential benefit outweighs risk to the fetus.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Neokay can interact with several medications that affect coagulation pathways.

Major Interactions (Avoid)

• Warfarin: may markedly reduce anticoagulant effect, leading to clot formation.
• Broad‑spectrum antibiotics: can alter gut flora and reduce vitamin K synthesis, enhancing Neokay effect.
• High‑dose vitamin E: may antagonize vitamin K activity, decreasing efficacy.

Moderate Interactions (Monitor Closely)

• Other anticoagulants (e.g., direct oral anticoagulants): may require dose adjustment.
• Lipid‑lowering agents (e.g., statins): occasional reports of altered coagulation parameters.
• Herbal supplements containing coumarin: potential additive effect on vitamin K pathways.